Exact Sciences price target lowered to $67 from $70 at Baird
The Fly

Exact Sciences price target lowered to $67 from $70 at Baird

Baird analyst Catherine Ramsey Schulte lowered the firm’s price target on Exact Sciences (EXAS) to $67 from $70 and keeps an Outperform rating on the shares. The firm said they reported 3Q revenue below expectations and meaningfully lowered 2024 revenue guidance, mainly attributed to weaker Screening trends.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App